CaseWorks Legal Podcast: Recent Episodes
Susan Barfield
Strategies and tactics to take your mass tort or personal injury law firm to the next level. Scale your legal practice and grow your firm with advice from legal industry thought leaders.
This week, our favorite mass tort attorney, Joe Fantini gives us updates on the latest in the industry. This Tort Talk Thursday covers: - Zantac: Defendants indicated they would be filing an appeal against the recent Daubert ruling in Delaware- Ozempic: JPML transferred MDL to new judge after Judge Pratter's unfortunate passing- Bair Hugger: First lawsuits dating back to 2015, this case has been revived. Promising news for plaintiffs!- Should you attend any legal conferences this year? Find out Joe and Susan's favorites on this year's lineup. How to reach Joe: Visit https://roseninjurylawyers.com/team/joseph-fantini/LinkedIn - https://www.linkedin.com/in/joseph-fantini/How to reach Case Works: Visit https://yourcaseworks.com/contact/LinkedIn - https://www.linkedin.com/company/your-case-worksDon't forget to turn on notifications to get the news first every Thursday!
On this special episode of The Leverage Report, Fu Zimmermann joins Susan in discussing the public nuisance panel at the upcoming Harris Martin Conference in Buffalo. She also dives into the latest happenings with the hottest torts right now, and what to expect for Shades of Mass this fall.
Connect with Fu on LinkedIn: https://www.linkedin.com/in/diandra-fu-debrosse-4bb3956/
Contact: https://dicellolevitt.com/attorney/diandra-fu-debrosse-zimmermann/
Follow Case Works on LinkedIn: https://www.linkedin.com/company/your-case-works/
Contact Us: https://yourcaseworks.com/contact/
Davis Vaughn joins Susan on The Leverage Report to discuss the status of JUUL and the FDA, commentary on the likeness of Social Media litigation, and the Harris Martin Conference in Buffalo on June 27, 2024.
Whole transcript available here: https://yourcaseworks.com/the-leverage-report/davis-vaughn-tells-all-juul-social-media-litigation/Learn More About Davis: https://www.beasleyallen.com/attorney/davis-vaughn/Follow Davis on LinkedIn: https://www.linkedin.com/in/davis-vaughn-74aa7558/🔔 Don't forget to subscribe and set up notifications! Learn more about Case Works: https://yourcaseworks.com/the-leverage-report/Follow Case Works on LinkedIn: https://www.linkedin.com/company/your-case-works/
Joe Fantini joins us with the latest updates and insights for another episode of Tort Talk Thursday! This week, Joe shares details regarding: 🟡 Talc Update: J&J settled a recent meso case that started in Dallas while working to gather support from 75% of claimants for bankruptcy; Plaintiffs filed a motion for preliminary injunction to prevent J&J from filing bankruptcy outside of NJ in a different bankruptcy court 🟡 Camp Lejeune: Upcoming deadline of August 10th to file administrative claim; with nearly 230,000 claims filed to date we are expecting another 10,000 in the next month and a total of 1,800 lawsuits filed; only 72 cases identified for Elective Option with 31 settlements accepted; this means cases will need to be resolved via trial and an order for selection of first bellwether trial for Tier 1 cases entered this week – plaintiffs will select 3 plaintiffs for 5 injuries and government select 2 plaintiffs for each for a total of 25 cases. Then, 45 days to complete fact discovery 🟡 RoundUp: motion to consolidate and form a multi-county litigation in NJ was denied; over 50,000 cases are pending with majority in Missouri state court; trials scheduled to kick off in Philly and CA state courts this summer🟡 Recommendations from Joe & Susan for legal conferences to attend this yearHow to get in contact with Joe:Email - jfantini@roseninjurylawyers.comLinkedIn - https://www.linkedin.com/in/joseph-fantini/See the full video transcript here: https://yourcaseworks.com/the-leverage-report/talc-bankruptcy-bellwether-trials-legal-conferences-2024/🔔Don't forget to subscribe and stay updated on the latest Mass Tort news!
In this episode of The Leverage Report, Rachel McCarthy discusses details of Milestone's solutions for law firms and plaintiffs.
Milestone, a settlement administration solutions provider, aims to prioritize the needs of plaintiffs while navigating the complex process of settlement distribution. Director of Strategic Partnerships, Rachel McCarthy, discusses Milestone's innovative approach to settlement administration, incorporating digital solutions, and trauma-informed care.Key Takeaways:1. Milestone's Solutions: Pathway, a digital platform, streamlines mass tort settlement distribution, allowing for efficient and flexible payment options, such as direct deposit, Zelle, PayPal, or digital Mastercard.
-
Trauma-Informed Approach: Milestone recognizes the potential trauma experienced by plaintiffs and trains its team on trauma-informed care through annual workshops with Dr. Laura McGuire, founder of the National Center for Equity and Agency.
-
Fee Deferral Program: Attorneys can defer contingency fees, invest their fees, and receive them later, allowing for strategic financial planning.
-
Milestone Foundation: Launched to provide low-interest funding to bridge the gap between lawsuit initiation and settlement, ensuring access to justice for those in need.
-
Scholarship Program: Milestone awards scholarships to promote diversity in the trial bar and to support female law students.
-
About the Conference: Attend the Harris Martin Mass Tort Settlements Conference (June 27th) in Buffalo to explore litigation topics, including public nuisance, toxic tort, sex abuse, and product device litigation.
-
About Reaching Out: Law firms and industry professionals can contact Milestone for a demo of Pathway or inquiry on settlement planning, fee deferral, or other solutions.Get in touch with Rachel:https://milestoneseventh.com/about-us/rachel-mccarthy/https://www.linkedin.com/in/rachel-mathews-mccarthy/See the full transcript here: https://yourcaseworks.com/the-leverage-report/rachel-mccarthy-provides-insight-into-milestones-solutions/
Joe Fantini joins us for another week on Tort Talk Thursday! During this episode, Joe shares details regarding: 🟡 Zantac Daubert ruling in Delaware, more injuries approved for lawsuit🟡 Deadlines to know for CPAP cases and global settlement🟡 Bard Hernia Mesh negotiations still working for remaining 20K cases🟡 Camp Lejeune insights and updates regarding the quick claims processHow to get in contact with Joe:Email - jfantini@roseninjurylawyers.comLinkedIn - https://www.linkedin.com/in/joseph-fantini/See the full video transcript here: https://yourcaseworks.com/the-leverage-report/6-6-24-tort-talk-thursday/🔔Don't forget to subscribe and stay updated on the latest Mass Tort news!
As we dive into the latest episode of the Leverage Report, we're excited to be joined by Rick Meadow, a renowned attorney with over 30 years of experience in the legal industry. In a fascinating conversation, Rick shares his insights on the growing concern of video game addiction and the potential legal implications. With addiction rates skyrocketing among children and teenagers, it's essential that we understand the root causes and the legal framework surrounding this issue. In this newsletter, we'll summarize the key takeaways, explore the legal grounds for filing a lawsuit, and discuss the evolving landscape of gaming addiction litigation.
Contact Rick Meadow: https://meadowlawfirm.com/richard-meadow/
See the full transcript here: https://yourcaseworks.com/the-leverage-report/video-game-addiction-lawsuits-with-rick-meadow/
In this week's episode of Tort Talk Thursday with Joe Fantini, he gives us the latest information on:1️⃣ Bard Hernia Mesh Mediation2️⃣ Zantac Trials3️⃣ Video Game Addiction MDL Announcements Expected Early June4️⃣ Unexpected Passing of Judge Pratter - What is Next for Ozempic?How to get in contact with Joe:Email - jfantini@roseninjurylawyers.comLinkedIn - https://www.linkedin.com/in/joseph-fantini/🔔Don't forget to subscribe and stay updated on the latest Mass Tort news!
For our Tort Talk Thursday episode this week, Joe Fantini and Susan Barfield discuss the latest mass tort developments:👶🏻 Toxic Baby Formula Lawsuit CMC🚙 Uber SA Lawsuit - Uber's Motion to Dismiss Denied👨🏽⚖️ New (Additional) Class Action Lawsuit Filed Against Johnson & Johnson⚖️ New (Additional) Whistleblower Lawsuit Filed Against ZantacHow to get in contact with Joe:Email - jfantini@roseninjurylawyers.comLinkedIn - https://www.linkedin.com/in/joseph-fantini/See the full video transcript here: https://yourcaseworks.com/the-leverage-report/5-23-24-tort-talk-thursday/🔔Don't forget to subscribe and stay updated on the latest Mass Tort news!
In this episode of The Leverage Report, Celine Cutter advises and answers FAQs regarding Uber and Lyft sexual assault cases. Key Takeaways:1. Ride-share companies like Uber and Lyft have faced multiple lawsuits for sexual assault allegations and are aggressively fighting back against the lawsuits.2. The cases involve complex legal issues and unique challenges, including the need for a trauma-informed approach and a team trained to work with victims of sexual assault.3. Establishing liability requires evidence of the ride taking place, including receipts, emails, or statements from witnesses.4. Upcoming technological advancements and policy changes may impact the industry and benefit victims.Get in touch with Celine:info@cutterlaw.comhttps://cutterlaw.com/attorneys/celine-cutter/See the full transcript here: https://yourcaseworks.com/the-leverage-report/celine-cutter-answers-rideshare-sexual-assault-litigation-faqs/
In light of the CPAP settlement offer and order last week, John Albanese joined us to discuss and summarize what to expect moving forward in the next few weeks.John provides the following actionable insights:1. Obtain Medical Records: Firms should obtain and review medical records quickly to ensure clients have qualifying injuries.2. Submit Identification Form: The settlement administrator will provide a template spreadsheet to be filled out and submitted through MDL Centrality by June 10.3. Participation Rate: The settlement requires a 95% participation rate from eligible claimants to participate in the settlement. Elapsed claimants can be removed from the participation rate calculation.To contact John or learn more about getting involved, you can email him at jalbanese@bm.netIf you need medical records pulled for your CPAP clients, reach out to us at Case Works at https://yourcaseworks.com/contact/ to learn about our quick and cost-efficient service -- Rapid Record Solutions!
May 16, 2024
Join us for more mass tort news this week on Tort Talk Thursday! During this episode, Joe Fantini discusses:
🔵 Consolidated actions for hair relaxer lawsuits in Illinois and Georgia
🔵 Recent AFFF developments
🔵 A lot of moving parts with Zantac litigation currently, four trials in motion
How to get in contact with Joe:
- Email - jfantini@roseninjurylawyers.com
- LinkedIn - https://www.linkedin.com/in/joseph-fantini/
See full video transcript here: https://yourcaseworks.com/the-leverage-report/hair-relaxer-aff-and-zantac-lawsuits-5-16-24/
May 9, 2024
Join us for more mass tort news this week on Tort Talk Thursday! During this episode, Joe Fantini discusses:
🔵 Zantac settlement from Pfizer and details of the 1st trial
🔵 RoundUp trials in St. Louis are underway and others scheduled
🔵 Camp Lejeune & AFFF case status updates regarding tiered injuries....and more!
How to get in contact with Joe:
- Email - jfantini@roseninjurylawyers.com
- LinkedIn - https://www.linkedin.com/in/joseph-fantini/
See the full video transcript here: https://yourcaseworks.com/the-leverage-report/5-9-24-tort-talk-thursday/
May 8, 2024
We come to you this week with a bonus episode of Tort Talk Thursday - Joe covers some intriguing developments for plaintiffs in CPAP, Talc, AFFF, and Bard Hernia Mesh litigation.
How to get in contact with Joe:
Email - jfantini@roseninjurylawyers.com
LinkedIn - https://www.linkedin.com/in/joseph-fantini/
See the full video transcript here: https://yourcaseworks.com/the-leverage-report/5-7-24-tort-talk-special-edition/
🔔Don't forget to subscribe and stay updated on the latest Mass Tort news!
May 2, 2024
In this week's episode of Tort Talk Thursday with Joe Fantini, he gives us the latest information on:
1️⃣ Paraquat MDL Judge Rules to Exclude Plaintiff Experts in 4 Bellwether Cases
2️⃣ Tylenol/Autism Second Expert Subject to Daubert
3️⃣ Mediation Update for Bard Hernia Mesh Cases
How to get in contact with Joe: Email - jfantini@roseninjurylawyers.com LinkedIn - https://www.linkedin.com/in/joseph-fantini/
See the full video transcript here: https://yourcaseworks.com/the-leverage-report/5-2-24-tort-talk-thursday/
🔔Don't forget to subscribe and stay updated on the latest Mass Tort news!
April 25, 2024
Joe Fantini shares hot mass tort news this week on Tort Talk Thursday! During this episode, Joe Fantini discusses:
⚖️ Recent Talc Powder Verdicts - one for defense and one for plaintiffs
🍼 Initial case management conference date announced for new baby food MDL
📢 Ozempic plaintiff leadership and liaison announced
How to get in contact with Joe: Email - jfantini@roseninjurylawyers.com LinkedIn - https://www.linkedin.com/in/joseph-fantini/
See the full video transcript here: 🔔Don't forget to subscribe and stay updated on the latest Mass Tort news!
April 18, 2024
Join us for more mass tort news this week on Tort Talk Thursday! During this episode, Joe Fantini discusses:
🍼 New baby food MDL approved by JPML
⏰ Deadline reminders for Camp Lejeune admin claims and Boy Scouts questionnaires
⚖️ PFAS Settlement news
....and more!
How to get in contact with Joe:
Email - jfantini@roseninjurylawyers.com
LinkedIn - https://www.linkedin.com/in/joseph-fantini/
See the full video transcript here: https://yourcaseworks.com/the-leverage-report/4-18-24-tort-talk-thursday/
🔔Don't forget to subscribe and stay updated on the latest Mass Tort news!
April 3, 2024
Join us on The Leverage Report this week, featuring Steve Levin. Steve covers details about major lawsuits filed by attorneys across 40+ states, who are coordinating efforts through the courts to hold social media companies accountable. Through the discovery process, lawyers hope to expose what companies know about how their algorithms are deliberately designed for addiction over safety. Jury decisions may be the only way to force meaningful changes to products and policies.
Connect with Steve Levin 🔗
Email: sml@levinperconti.com
LinkedIn: https://www.linkedin.com/in/chicagonursinghomeattorney/
Find the whole transcript here: https://yourcaseworks.com/the-leverage-report/holding-social-media-companies-accountable-with-litigation-featuring-steve-levin/
April 11, 2024
For our Tort Talk Thursday episode this week, Joe Fantini and Susan Barfield recap the spring 2024 MTMP conference, revealing the latest in mass tort litigation.
How to get in contact with Joe:
Email - jfantini@roseninjurylawyers.com
LinkedIn - https://www.linkedin.com/in/joseph-fantini/
See the full video transcript here: https://yourcaseworks.com/the-leverage-report/april-2024-mtmp-recap/
🔔Don't forget to subscribe and stay updated on the latest Mass Tort news!
April 2, 2024
In this week's episode of Tort Talk Thursday with Joe Fantini, he gives us the latest information on:
1️⃣ Hernia Mesh Strattice and Bard Updates
2️⃣ New Cases Examined by JPML: Baby Food & Sex Trafficking
3️⃣ Uber Sexual Assault MDL Developments
4️⃣ CPAP Updates
5️⃣ MTMP Conference April 3-5
How to get in contact with Joe: Email - jfantini@roseninjurylawyers.com LinkedIn - https://www.linkedin.com/in/joseph-fantini/
See the full video transcript here: https://yourcaseworks.com/the-leverage-report/3-28-24-tort-talk-thursday/
🔔Don't forget to subscribe and stay updated on the latest Mass Tort news!
March 27, 2024
For this week's episode of The Leverage Report, we hear Dave Cate's recollection of the events that led up to the $60M NEC Verdict that he obtained for the deserving family.
To connect with Dave Cates regarding his experience or other legal questions:
Email: dcates@cateslaw.com
LinkedIn: https://www.linkedin.com/company/cates-law-firm-llc/
See the full transcription here: https://yourcaseworks.com/the-leverage-report/david-cates-provides-insights-to-60m-nec-verdict/
Mar 20, 2024
Welcome to this week's episode of Tort Talk Thursday with Joe Fantini! In this video, Joe gives us the latest information on:
-
$60 Million NEC verdict
-
Will Bayer File for Bankruptcy?
-
Hair Relaxer Lawsuit Developments
-
Social Media Lawsuits
How to get in contact with Joe: Email - jfantini@roseninjurylawyers.com LinkedIn - https://www.linkedin.com/in/joseph-fantini/
See the full video transcript here: https://yourcaseworks.com/the-leverage-report/3-21-24-tort-talk-thursday/
Don't forget to subscribe and stay updated on the latest Mass Tort news!
March 13, 2024
Did you catch Ryan Stephen's Panel at LITFINCON? On our latest episode of The Leverage Report, we had the pleasure of discussing Ryan's recap of the conference and how Pine Valley Capital Partners offers secure and strategic litigation financing.
For more information, reach out to Pine Valley Capital directly at hello@pvcapitalpartners.com or Ryan on LinkedIn at https://www.linkedin.com/in/ryanstephen/.
March 14, 2024
Welcome to this week's episode of Tort Talk Thursday with Joe Fantini! In this video, Joe gives us the latest information on:⚖️Recent RoundUp Trials💊Zantac Lawsuit Updates💼Ozempic Case Management Conference🤔Upcoming Potential Mass TortsHow to get in contact with Joe:Email - jfantini@roseninjurylawyers.comLinkedIn - https://www.linkedin.com/in/joseph-fantini/See the full video transcript here: https://yourcaseworks.com/the-leverage-report/3-14-24-tort-talk-thursday/🔔Don't forget to subscribe and stay in on the latest Mass Tort news!
March 7, 2024
Welcome to this week's episode of Tort Talk Thursday with Joe Fantini! In this video, Joe gives us the latest information on:
💧Camp Lejeune Tier 2 Cases
⚖️Recent RoundUp Trials
🗓️Upcoming CPAP Case Management Conference
📄Suboxone Filings
🚙Uber Assault Cases
How to get in contact with Joe:
Email - jfantini@roseninjurylawyers.com
LinkedIn - https://www.linkedin.com/in/joseph-fantini/
See the full video transcript here: https://yourcaseworks.com/the-leverage-report/3-7-24-tort-talk-thursday/
🔔Don't forget to subscribe and stay in on the latest Mass Tort news!
March 14, 2024
On this episode of The Leverage Report, we hear all the details about the case management conference for Ozempic that occurred March 14th, 2024. We had the pleasure of discussing Danae Benton's recap of the conference and getting insights into how the Ozempic MDL will move forward.
To connect with Danae Benton regarding pending Ozempic lawsuits, reach out to her directly: Email: dbenton@cochrantexas.com LinkedIn: https://www.linkedin.com/in/danae-n-benton-49599340/
See the full transcription here: https://yourcaseworks.com/the-leverage-report/danae-benton-recaps-march-14th-ozempic-case-management-conference/
March 6, 2024
Bard Port Catheter MDL Litigation Update: What Plaintiffs Firms Need to Know
The multidistrict litigation over Bard's allegedly defective port catheters continues to rapidly progress, requiring close attention from plaintiffs attorneys assisting harmed patients. In Case Works’ recent podcast interview with members of the leadership team, including attorneys from Berger Montague, we discussed critical updates on this litigation expected to move swiftly to bellwether trials by late 2025.
With over 100 lawsuits consolidated in Arizona federal court, Judge David Campbell is moving this MDL forward at an aggressive pace. Leadership has been appointed, discovery is underway, and the initial bellwether pool is set. Attorneys assisting plaintiffs should closely track litigation developments to ensure their clients' rights are fully protected as we rapidly approach trial.
Interested in connecting with the attorneys of Berger Montague?
Shanon Carson: scarson@bm.net
Jennifer Elwell: jelwell@bm.net
John Albanese: jalbanese@bm.net
Or visit https://bergermontague.com/contact-us/
See the full video with transcript here: https://yourcaseworks.com/the-leverage-report/bard-powerport-cathedar-lawsuit-updates-with-berger-montague/
March 6, 2024
Ken Reimer dives deep into Case Works' Rapid Record Solution that is sure to show your true marketing ROI when it comes to validating leads!
Connect with Ken: https://yourcaseworks.com/contact/
https://yourcaseworks.com/the-leverage-report/rapid-record-solutions-enhances-roi-validated-leads/
February 29, 2024
Welcome to another episode of Tort Talk Thursday with Joe Fantini!
How to get in contact with Joe:
Email - jfantini@roseninjurylawyers.com
LinkedIn - https://www.linkedin.com/in/joseph-fantini/
See the full video transcript here: https://yourcaseworks.com/the-leverage-report/2-26-updates-tort-talk-thursday/
🔔Don't forget to subscribe and stay in on the latest Mass Tort news!
.
.
.
During this week's episode, Attorney Joe Fantini provided a thorough update on several major ongoing mass tort lawsuits. He covered recent developments across key cases involving hernia mesh products, the Boy Scouts settlement, as well as emerging litigation around the medications Suboxone and Ozempic.
Starting with hernia mesh, Joe noted a bellwether trial is scheduled to begin next week in New Jersey state court focused on cases involving Stratus mesh. This will be a significant data point, given trials have been rare so far in the hernia mesh litigation. In addition, the federal judge overseeing the largest hernia mesh MDL against C.R. Bard, consisting of over 40,000 filed cases, has ordered the parties to mediate beginning March 3rd and 4th. After years of these cases progressing, requiring mediation is a promising indication that we could see meaningful resolution on the horizon for plaintiffs.
Regarding the Boy Scouts settlement, Joe explained the positive update that the court lifted a temporary stay blocking the settlement after an appeal from survivors seeking more time to submit claims. With the stay removed, the settlement is now moving forward once again, with the claim form deadline still set for May 31st. Assuming forms are filed in time, Joe anticipates compensation will start heading to victims of abuse later this year as the claims are evaluated and approved.
As for newly formed lawsuits, Joe provided details on both the Suboxone and Ozempic MDLs. For Suboxone, the initial case management conference is scheduled for early March before the federal judge in the Eastern District of Pennsylvania. The litigation is focused on patients who took brand name Suboxone to treat opioid addiction for over 30-90 days and subsequently experienced severe dental problems like tooth decay that required oral surgery. The key criteria is that the medication must have been taken prior to an important label change in 2022 warning of these dental risks.
At the same time, Ozempic's initial conference is slated for March 14th. The judge is taking a unique approach to get out in front of certain issues before entering any formal orders. There will be an initial meeting to discuss appointing leadership counsel, the process for case filings and discovery, as well as evaluating whether to segment or group defendants who have varying products consolidated in the MDL. Joe expects the leadership structure will be formalized before the end of spring.
In summary, it's an active period across the mass tort landscape with momentum building on major established litigation like hernia mesh while new cases quickly emerge and ramp up. We anticipate learning much more following the imminent initial conferences for Suboxone and Ozempic.
February 21, 2024
Learn more about Case Works' fee deferral solution on our website: https://yourcaseworks.com/solutions/
______________________________________________________________
The litigation financing industry has experienced explosive growth in recent years, with market size estimates projecting it will be a $20 billion industry within the next 4-5 years. This influx of capital has fundamentally changed the dynamics for law firms, allowing them to take on significantly larger case inventories than ever before. But this rapid growth also creates challenges - how can law firms fund the upfront costs associated with acquiring and developing large dockets of cases?
This is where fee deferral comes in. Fee deferral solutions allow law firms to defer paying fees for case development services until the time of settlement. Rather than paying these costs upfront, firms can redeploy that capital into acquiring even more cases. This approach unlocks substantial financial leverage and improves ROI by a staggering 40-50%.
However, not all fee deferral offerings are created equal. Many providers fund fee deferrals through their own balance sheet, taking on risk until settlement. To reduce their risk exposure, these providers often prioritize near-settlement cases while letting other cases languish untouched for years. Law firms working with these partners routinely complain of having no visibility into case progress and inactive cases.
Case Works has structured their fee deferral solution to align incentives and provide transparency for law firms. Rather than putting their own balance sheet at risk, Case Works partners with third-party litigation funders who take on the risk associated with deferred fees. This enables Case Works to work every case equally, applying the same high-touch approach regardless of where the case sits in the litigation timeline.
Law firms exploring fee deferral solutions should ask potential partners key questions, like: What other cases are you working on? How will you fund the work? Are you comfortable with pre-Daubert torts? Do you provide reporting transparency? Case Works' approach delivers the consistency, transparency, and experience law firms need to optimize fee deferral.
The exponential growth in litigation financing has unlocked substantial opportunities for law firms to scale. But realizing that potential hinges on implementing the right fee deferral solution. With the appropriate partner, fee deferral can provide law firms with a strategic lever to unlock transformative growth.
February 21, 2024
Subscribe and turn on notifications to stay tuned for the next Tort Talk Thursday! 🔔
💻Learn more about how Case Works can assist your law firm by visiting us at: https://yourcaseworks.com/contact/
📲Connect with Joe and get his latest insights on LinkedIn: https://www.linkedin.com/in/joseph-fantini/
📲Connect with Susan (Mass Tort Maven) to get the latest and greatest information on LinkedIn: https://www.linkedin.com/in/susan-barfield/
PRESENTING Tort Talk Thursdays, hosted by Susan Barfield and Joe Fantini. Experienced mass tort attorney Joe Fantini joins host Susan to provide updates on major ongoing mass tort litigation as of February 2024. Joe begins by giving background on his extensive experience in mass tort law, including working on the plaintiff side, defense side, and clerking for a dedicated mass tort court. This diverse perspective gives him unique insights.
The first case they discuss is the Boy Scouts bankruptcy settlement. After years of negotiations, a $2.4 billion settlement was reached and approved on appeal. However, a group of plaintiffs recently petitioned the Supreme Court to stay the bankruptcy proceedings, arguing that non-bankrupt local councils and individuals shouldn't get liability protections through the bankruptcy. Justice Alito granted a stay, with a decision expected alongside the similar Purdue Pharma case. For firms with Boy Scout cases, Joe recommends continuing to prepare claims materials to be ready when the stay lifts.
Next, they cover recent developments in RoundUp litigation. After a string of defense verdicts in 2022, plaintiffs have momentum again thanks to recent large jury awards by firms like Klein and Specter and Arnold Itkin. With about a dozen more trials scheduled through mid-year, Joe expects global or inventory settlements to pick up.
Another important update, as Michigan repealing its pharmaceutical immunity law, which had provided blanket immunity to drug companies. This opens the door to opioid and other drug injury lawsuits in Michigan for harms occurring after 2/13/23.
One emerging mass tort poised for major growth is Ozempic. With over 10,000 expected cases, the litigation was recently consolidated before Judge Pratter in the Eastern District of Pennsylvania. Joe explains the injury criteria, including 30+ days of use, hospitalized GI injuries 30+ days after starting, and no prior gastric procedures. He anticipates significant activity in the second half of 2023.
Another likely new MDL is baby food litigation, after a prior consolidation attempt failed. A new petition cites over 3,500 plaintiffs. Key factors are autism or ADHD diagnoses 2+ years after 12+ months of baby food use. An early bellwether trial is already scheduled for this summer.
Feb 20, 2024
To learn more about how Case Works can assist your law firm with large torts like Ozempic, visit our website at https://yourcaseworks.com/contact/.
Contact Jonathan:
jsedgh@forthepeople.com
(212) 738-6839
https://www.linkedin.com/in/jonathan-sedgh-29480323b/
Video Details:
The popular diabetes medication Ozempic is being widely prescribed off-label for weight loss, but it is causing severe and lasting gastrointestinal injuries in many patients. Attorney Jonathan Sedgh with Morgan & Morgan provided an in-depth look at the growing Ozempic injury litigation on a recent episode of The Leverage Report.
Ozempic belongs to a class of drugs called GLP-1 receptor agonists that work by slowing down the digestive tract. In many patients, Ozempic goes far beyond just slowing digestion—it paralyzes the stomach, leading to gastroparesis.
With gastroparesis, food gets stuck in the digestive tract and cannot make it down into the small intestines to be properly digested. This undigested food can form into balls or clusters, leading to bowel obstructions and intestinal blockages. Patients experience severe and persistent vomiting, requiring emergency room visits and hospitalization for dehydration. They end up on IV fluids, unable to keep any food or liquids down.
For many patients, the debilitating gastrointestinal symptoms continue even after stopping Ozempic, indicating the drug has caused permanent damage. The main defendants in the growing litigation are Novo Nordisk, maker of Ozempic, and Eli Lilly, which makes the competing GLP-1 drug Trulicity.
So far, about 60 cases have been filed in federal court, but Morgan & Morgan alone is investigating over 10,000 potential cases. Sedge estimates there could be 50,000 to 60,000 potential cases nationwide based on the volume of inquiries they receive.
Due to the large number of federal cases, an MDL (multidistrict litigation) was recently created to consolidate the Ozempic lawsuits in front of the experienced Judge Pratter in the Eastern District of Pennsylvania. This will help streamline the litigation process.
According to Sedgh, important criteria for Ozempic cases include:
- Treated at a hospital or ER for injuries like vomiting, dehydration
- Persistent vomiting for at least 1 month
- Off Ozempic when they learned of the risks and contact the law firm
He notes key challenges will be proving Ozempic directly caused the gastrointestinal injuries and combatting defense arguments that preexisting conditions like diabetes or obesity were the real cause. This litigation is gaining momentum with tens of thousands of potential cases. Sedgh provides invaluable insights into the Ozempic injury landscape that is still emerging. He stresses the importance of thoroughly screening cases and obtaining all necessary medical records for anyone considering getting involved.
In this enlightening conversation, join Mike Papantonio as he sits down with Founder Susan Barfield and Ken Reimer, of Case Works, to discuss the critical issues plaguing the mass tort legal industry. With a focus on the rise of fraudulent practices in mass tort lead generation, Susan and Ken provide valuable insights into the challenges faced by law firms today and how to avoid the pitfalls so that you can ultimately protect your greatest asset… Your Firm, Your Team, Your Investment, and most importantly Your Clients.
Welcome back to another episode of The Leverage Report. Today, we're learning about the latest on the Sexual Abuse cases and what's happening in Maryland to protect child survivors of sexual abuse.
Get an exclusive sneak peek at what's going down at the Women in Legal Leadership Breakfast happening on 10/12 at MTMP 2023!
Today we've got a special edition of The Leverage Report with what you need to know from the Boy Scout update on 9/26/23.
In this episode of The Leverage Report, we bring you Hunter Shkolnik! In this interview, we talk about all things MTMP and the ethical conundrums of mass torts.
Check out this week's Leverage Report for an MTMP sneak peak with Mark Abramowitz & Ashlie Case Sletvold into the Tepezza litigation.
Andy Childers gives us an exclusive update on all things Mass Torts Made Perfect and the topics that he'll be speaking on. This includes Chemical Hair Relaxer, Infant Formula, and Paraguard litigations.
Today on the Leverage Report we are joined by Stephen Reck and Jose Rojas with an exclusive update on the NEC litigation.
Carl Solomon of The Solomon Law Group & Greg Cade of The Environmental Litigation Group join the Case Works stream to discuss the recent updates in the AFFF litigation.
Case Works' Director of Operations Mary Mick joins the Case Work stream to discuss why case works culture matters to your firm and your clients.
Sharon Boothe Vice President of Programs for Mass Torts Made Perfect, joins the Case Works' stream to discuss MTMP Spring 2023. In this video they go over:-When and where is MTMP Spring 2023-What are the hot Mass Torts -What are some can't miss business of law sessions-What entertainment is booked-How to make the most out of MTMP-How to register last minute and still get a room
Updates and Insights by Case Works' General Counsel Bill Barfield on what is going on in the Hair Straightener Litigation
Fu Zimmermann of Dicello Levitt Group joined the Case Works The Leverage Report stream to discuss the recent updates on the exciting Shades of Mass event happening in Miami Beach.
Susan and Patrick Luff discuss the importance of managing the client experience for mass tort clients once they become a client of your firm. Staying engaged and proactive throughout the multi-year MDL process reduces dual representation and MIA clients.
Patrick Luff of the Luff Law Firm dives into the questions everyone wants to know about this litigation including details on the judge, which entities are potentially liable, and what the timeline looks like for Daubert and the MDL.
Gregory Cade, Darren Miller, & Adam Binder discuss AFFF firefighting foam lawsuits with Case Works's Susan Barfield.
Recently gaining national attention, Darren Miller & Danielle Mason dissect hair straightener cancer lawsuits.
Michael Blom and Rebecca Sheppard discuss the details of the ERTC and how law firms are helping businesses claim the credit.
Susan Barfield sits down with Michael DeMayo to discuss client-first practices at plaintiff firms.
Cooper Hurley Chief Marketing Officer Cassidy Lewis and Case Works’ Susan Barfield walk through Cassidy’s framework for growing your firm through strategic marketing initiatives.
Matthew Bergman, Social Media Andrew Bergman of Social Media Victims Law Center explains why he transitioned his practice to not only compensate victims of social media addiction, but work to prevent it in the first place. Law Center, discusses cases involving parents of social media victims.
Erin Copeland of Fibich Leebron Copeland & Briggs explains the MDL process and also offers the latest updates to Paragard litigation.
Amy Collins joins Susan Barfield to explain the Common Benefit Process in Mass Torts. Amy Collins P.C. provides independent third-party common benefit legal consulting and auditing services for leadership counsel, fee committees, special masters, and courts in multidistrict litigation state court coordinated proceedings.
Susan Barfield is joined by her brother Bill Barfield of McDonald Worley to discuss tips on how to manage a high volume of mass tort cases.
Steve Babin & Kristina Aiad-Toss discuss the complexities of human trafficking litigation.
CPAP plaintiff leadership committee member Syreeta Poindexter updates the Case Works team on CPAP litigation.
Lexshares Chief Investment Officer and Co-Founder Max Volsky discusses the state of litigation funding and non-recourse mass tort financing.
CPAP Plaintiff Steering Committee members Michael Ram of Morgan & Morgan and Lauren Miller of Hagens Berman Sobol Shapiro LLP discuss the most recent updates to the litigation.
Joe Siprut is the CEO of Kerberos Capital Management which provides innovative capital solutions to law firms. Prior to founding Kerberos, joe was a nationally recognized litigation attorney specializing in class actions and mass torts.
Berger Montague attorney and CPAP leadership member Shanon Carson is joined by fellow Berger Montague lawyers John Albanese & Dena Young to discuss the current state of CPAP litigation in 2022.
Richard Meadow & Danielle Mason discuss the latest updates to Talcum Powder litigation including the February 2022 ruling.
Keller Lenkner attorneys Seth Meyer & Amelia Frenkel discuss the most recent progress on Necrotizing Enterocolitis litigation against baby formula manufacturers.
Darryl "The Hammer" Isaacs of Isaacs & Isaacs shares his insights on how to grow your personal injury law firm.
Chad Dudley of Dudley DeBosier and co-founder of Vista Consulting joins Susan to discuss how to run your law firm as a business through the use of technology, automation, and best practices.
Managing Partner and Chief Operating Officer of Richard Schwartz & Associates law firm, Patrick Wooten, joins Case Works' Susan Barfield to discuss the delays COVID put on the personal injury processes and legal system from courts to medical records retrieval.
Co-Lead on the Bard Hernia Mesh MDL and attorney at Fleming Nolan Jez, Kelsey Stokes discusses the latest updates on hernia mesh litigation.
Detroit attorney and author Mike Morse joins Susan Barfield to discuss his book Fireproof, and how law firms can use his five-step program to make themselves more efficient, more profitable, and more resilient to external issues.
Mike Lyons of Lyons & Simmons and Jon Robinson of CAMG join Susan Barfield to discuss the future of personal injury litigation.
Joe Fantini of Rosen Injury Lawyers joins CaseWorks to discuss how to get started in mass torts, and the differences between mass tort and single-event personal injury case acquisition and development.
Bill Denninger of Datavative joins CaseWorks to discuss how to interview for intake and administrative roles in your firm. Bill also comments on the use of technology and how to properly screen for technological proficiency.
Chris Princis of CAMG (Consumer Attorney Marketing Group) joins CaseWorks to discuss how and when your firm should consider entering a mass tort litigation.
Dave Thomas of Law Tigers joins CaseWorks to discuss how personal injury lawyers and law firms can leverage the power of community building and grassroots marketing to grow their law firm and improve their reputation.
Yehia Said of Datavative joins CaseWorks to discuss the vetting and managing of third-party legal service providers.
Dov Slansky, VP Solution Engineering of Litify discusses the streamlined processes and use of technology to improve mass tort client intake and signup.